Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 10:28 am Purchase |
2022-12-31 | 13G | Autolus Therapeutics plc AUTL |
Syncona Portfolio Ltd | 33,527,162 19.700% |
14,000,000 (+71.70%) |
Filing History |
| 2023-02-14 08:30 am Unchanged |
2022-12-31 | 13G | Autolus Therapeutics plc AUTL |
Deep Track Capital, LP | 15,000,000 8.670% |
0 (Unchanged) |
Filing History |
| 2023-02-13 2:49 pm Sale |
2023-02-14 | 13G | Autolus Therapeutics plc AUTL |
Capital World Investors | 625,000 0.400% |
-2,330,806 (-78.86%) |
Filing History |
| 2022-12-19 4:11 pm Purchase |
2022-12-09 | 13G | Autolus Therapeutics plc AUTL |
Deep Track Capital, LP | 15,000,000 9.030% |
15,000,000 (New Position) |
Filing History |
| 2022-12-13 4:51 pm Purchase |
2022-12-08 | 13D | Autolus Therapeutics plc AUTL |
Blackstone Inc. BX |
23,750,917 14.000% |
2,500,000 (+11.76%) |
Filing History |
| 2022-12-13 4:50 pm Purchase |
2022-12-09 | 13G | Autolus Therapeutics plc AUTL |
Qatar Investment Authority | 15,000,000 9.030% |
15,000,000 (New Position) |
Filing History |
| 2022-10-05 4:21 pm Purchase |
2022-09-23 | 13D | Autolus Therapeutics plc AUTL |
PPF Biotech B.V. | 14,613,275 16.100% |
1,000 (+0.01%) |
Filing History |
| 2022-02-14 5:03 pm Purchase |
2021-12-31 | 13G | Autolus Therapeutics plc AUTL |
Nantahala Capital Management, LLC | 4,077,509 5.600% |
4,077,509 (New Position) |
Filing History |
| 2022-02-11 12:21 pm Purchase |
2021-12-31 | 13G | Autolus Therapeutics plc AUTL |
Syncona Portfolio Ltd | 19,527,162 26.800% |
3,571,428 (+22.38%) |
Filing History |
| 2021-12-17 2:37 pm Purchase |
2021-12-13 | 13G | Autolus Therapeutics plc AUTL |
Frazier Life Sciences Public Fund, L.P. | 3,730,657 5.100% |
3,730,657 (New Position) |
Filing History |
| 2021-11-16 4:07 pm Purchase |
2021-11-06 | 13D | Autolus Therapeutics plc AUTL |
Blackstone Inc. BX |
21,250,917 22.600% |
21,250,917 (New Position) |
Filing History |
| 2021-06-23 4:00 pm Purchase |
2021-05-18 | 13D | Autolus Therapeutics plc AUTL |
PPF Biotech B.V. | 14,612,275 27.900% |
361,255 (+2.53%) |
Filing History |
| 2021-02-17 5:01 pm Sale |
2021-02-12 | 13D | Autolus Therapeutics plc AUTL |
Arix Bioscience plc | 3,319,866 4.800% |
-50,000 (-1.48%) |
Filing History |
| 2021-02-16 11:42 am Purchase |
2021-02-16 | 13G | Autolus Therapeutics plc AUTL |
Capital World Investors | 2,955,806 5.700% |
2,955,806 (New Position) |
Filing History |
| 2021-02-12 10:43 am Purchase |
2020-12-31 | 13G | Autolus Therapeutics plc AUTL |
Syncona Portfolio Ltd | 15,955,734 30.500% |
1,363,636 (+9.35%) |
Filing History |
| 2021-01-08 4:15 pm Purchase |
2021-01-01 | 13D | Autolus Therapeutics plc AUTL |
Arix Bioscience plc | 3,369,866 6.400% |
208,333 (+6.59%) |
Filing History |
| 2020-08-13 4:09 pm Purchase |
2020-08-12 | 13D | Autolus Therapeutics plc AUTL |
PPF Biotech B.V. | 14,251,020 27.300% |
553,075 (+4.04%) |
Filing History |
| 2020-08-03 4:12 pm Purchase |
2020-07-31 | 13D | Autolus Therapeutics plc AUTL |
PPF Biotech B.V. | 13,697,945 26.200% |
604,370 (+4.62%) |
Filing History |
| 2020-07-20 4:10 pm Purchase |
2020-07-17 | 13D | Autolus Therapeutics plc AUTL |
PPF Biotech B.V. | 13,093,575 25.100% |
519,266 (+4.13%) |
Filing History |
| 2020-07-06 4:15 pm Purchase |
2020-07-02 | 13D | Autolus Therapeutics plc AUTL |
PPF Biotech B.V. | 12,574,309 24.100% |
531,029 (+4.41%) |
Filing History |